Episode 128 - Colin Meyer, MD

I'm Aware That I'm Rare: the phaware® podcast

English - February 12, 2018 13:00 - 10 minutes - 9.78 MB - ★★★★★ - 14 ratings
Health & Fitness Government awareness cteph pah research advocacy asthma breathlessness caregiver clinicaltrials earlydiagnosis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Scott Manaker, MD, PhD - phaware® interview #127

Next Episode: Colin Meyer, MD phaware® interview #128

Colin Meyer, MD is Reata Pharmaceutical’s Chief Medical Officer and leads product development and strategy, clinical trial design and analysis, and medical affairs. Colin received a B.S. in chemistry with specialization in biochemistry and a B.A. in biology from the University of Virginia. He received an M.D. from the University of Texas Southwestern Medical School and an M.B.A. from Southern Methodist University Cox School of Business. In this episode he discusses the process of how a drug goes from invention to market.

Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD

Learn more about the Phase 3 CATALYST trial: www.catalysttrial.com